Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

606 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Riedel's Thyroiditis: Report of Two Cases and Literature Review.
Blanco VM, Páez CA, Victoria AM, Arango LG, Arrunategui AM, Escobar J, Martínez V, Guzmán GE. Blanco VM, et al. Among authors: escobar j. Case Rep Endocrinol. 2019 Dec 9;2019:5130106. doi: 10.1155/2019/5130106. eCollection 2019. Case Rep Endocrinol. 2019. PMID: 31929916 Free PMC article.
Peritoneal tuberculosis in an immunocompetent patient: A case report.
Echeverri-Fernandez E, Amezquita MA, Moncada PA, Escobar J, Fernandez-Trujillo L. Echeverri-Fernandez E, et al. Among authors: escobar j. IDCases. 2023 May 11;32:e01785. doi: 10.1016/j.idcr.2023.e01785. eCollection 2023. IDCases. 2023. PMID: 37234728 Free PMC article.
Sevelamer-induced Gastrointestinal Mucosal Injury: A Critical Review for Clinicians.
Bathobakae L, Phuu P, Yasin S, Bashir R, Escobar J, Yuridullah R, Melki G, Elagami M, Amer K, Cavanagh Y, Baddoura W. Bathobakae L, et al. Among authors: escobar j. J Community Hosp Intern Med Perspect. 2024 Nov 2;14(6):58-65. doi: 10.55729/2000-9666.1424. eCollection 2024. J Community Hosp Intern Med Perspect. 2024. PMID: 39839182 Free PMC article. Review.
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, Żotkiewicz M, Udoye SI, Kurland JF, Cohen GJ, Lencioni R; EMERALD-1 Investigators. Sangro B, et al. Among authors: escobar j. Lancet. 2025 Jan 18;405(10474):216-232. doi: 10.1016/S0140-6736(24)02551-0. Epub 2025 Jan 8. Lancet. 2025. PMID: 39798579 Clinical Trial.
606 results